Company recalls anticoagulant
SCA Pharmaceuticals has recalled 10 lots of compounded heparin sodium, an anticoagulant packaged in 500 mL or 1000 mL intravenous bags, the Food and Drug Administration announced yesterday. The bags contain the undeclared benzyl alcohol, a preservative that can cause serious adverse reactions in premature and low birth weight infants.
Related News Articles
Headline
Erica Taylor, M.D., orthopedic surgeon and vice president of health equity at Duke Health, shares how the organization’s frontline liaison network is helping…
Headline
The Department of Health and Human Services Oct. 20 launched a national plan focused on kidney care. HHS said the plan would address the root cause of kidney…
Headline
There are now 1,136 confirmed measles cases in Pennsylvania this year amid the state’s outbreak, the Pennsylvania Department of Health announced Oct. 9. Of…
Chairperson's File
Hospitals and health systems — traditionally focused on acute care — are increasingly becoming more involved in primary care. There is tremendous value for…
Headline
The deadline to apply for the inaugural AHA Age-Friendly Healthcare Impact Award is Sept. 25. The award, created by the AHA and The John A. Hartford Foundation…
Headline
The Substance Abuse and Mental Health Services Administration announced Sept. 18 that it awarded $42.3 million in grants to states and territories to support…